Investigación / Grupos de investigación

Grupo  2

Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Publicaciones (372)

  • Pineda-Tenor, D; Berenguer, J; Garcia-Broncano, P; Jimenez-Sousa, MA; Fernandez-Rodriguez, A; Diez, C; Garcia-Alvarez, M; Carrero, A; Catalan, P; Aldamiz-Echevarria, T; Resino, S.

    Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients

    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2014; 44(5): 453-462 Nº de citas: 14 [doi:10.1111/eci.12250]

  • Rodriguez, RP; Galligo, EM; Iribarren, JA; Pedrol, PD; Garcia, ML; de Mallorca, P; Montesinos, VM; Martin, PM; Julian, AN; Hernandez, AO; Bares, MLP; Franch, AS; Beneitez, MCV; Tome, MIG.

    Executive Summary of the Consensus Statement on monitoring HIV: Pregnancy, birth, and prevention of mother-to-child transmission

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2014; 32(5): 311-319 Nº de citas: 3 [doi:10.1016/j.eimc.2013.12.006]

  • Jimenez-Sousa, MA; Berenguer, J; Fernandez-Rodriguez, A; Micheloud, D; Guzman-Fulgencio, M; Miralles, P; Pineda-Tenor, D; Garcia-Alvarez, M; Lopez, JC; Aldamiz-Echevarria, T; Carrero, A; Resino, S.

    IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients

    JOURNAL OF VIRAL HEPATITIS. 2014; 21(3): 189-197 Nº de citas: 9 [doi:10.1111/jvh.12130]

  • Perez-Latorre, L; Sanchez-Conde, M; Rincon, D; Miralles, P; Aldamiz-Echevarria, T; Carrero, A; Tejerina, F; Diez, C; Bellon, JM; Banares, R; Berenguer, J.

    Prediction of Liver Complications in Patients With Hepatitis C Virus-Related Cirrhosis With and Without HIV Coinfection: Comparison of Hepatic Venous Pressure Gradient and Transient Elastography

    CLINICAL INFECTIOUS DISEASES. 2014; 58(5): 713-718 Nº de citas: 25 [doi:10.1093/cid/cit768]

  • Guzman-Fulgencio, M; Garcia-Alvarez, M; Berenguer, J; Jimenez-Sousa, MA; Cosin, J; Pineda-Tenor, D; Carrero, A; Aldamiz, T; Alvarez, E; Lopez, JC; Resino, S.

    Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients

    JOURNAL OF INFECTION. 2014; 68(2): 176-184 Nº de citas: 25 [doi:10.1016/j.jinf.2013.10.011]

  • Ramirez, MLM; Miro, JM; Quereda, C; Jou, A; von Wichmann, MA; Berenguer, J; Gonzalez-Garcia, JJ; Hernando, A; Ortega, E; Sanz, J; Arribas, JR.

    Incidence of Hepatocellular Carcinoma in HIV-Infected Patients With Cirrhosis: A Prospective Study

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2014; 65(1): 82-86 Nº de citas: 8 [doi:10.1097/QAI.0b013e3182a685dc]

  • Fernndez-Rodriguez, A; Berenguer, J; Jimenez-Sousa, MA; Guzman-Fulgencio, M; Micheloud, D; Miralles, P; Lopez, JC; Bellon, JM; Aldamiz-Echevarria, T; Garcia-Broncano, P; Carrero, A; Alvarez, E; Resino, S.

    Prediction of Hepatic Fibrosis in Patients Coinfected With HIV and Hepatitis C Virus Based on Genetic Markers

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 2013; 64(5): 434-442 Nº de citas: 7

  • Domingo, P; Polo, R; Lozano, F; Aldeguer, JL; Aguirrebengoa, K; Estrada, V; Gutierrez, F; Knobel, H; Llibre, JM; Miralles, C; Miro, JM; Rivero, A; Santos, J; Tusset, M; Antela, A; Asensi, V; Arribas, JR; Blanco, JR; Boix, V; Garcia, F; Gatell, JM; Mallolas, J; Martinez, E; Moreno, S; Palacios, R; Perez-Elias, MJ; Pineda, JA; Vidal, F; Berenguer, J.

    Executive summary of the Consensus Document of GeSIDA and Spanish Secretariat for the National Plan on AIDS on combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2013)

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2013; 31(9): 604-613 Nº de citas: 3 [doi:10.1016/j.eimc.2013.04.010]

  • Blasco, AJ; Llibre, JM; Arribas, JR; Boix, V; Clotet, B; Domingo, P; Gonzalez-Garcia, J; Knobel, H; Lopez, JC; Lozano, F; Miro, JM; Podzamczer, D; Santamaria, JM; Tuset, M; Zamora, L; Lazaro, P; Gatell, JM.

    Analysis of costs and cost-effectiveness of preferred GESIDA/National AIDS Plan regimens for initial antiretroviral therapy in human immunodeficiency virus infected adult patients in 2013

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2013; 31(9): 568-578 Nº de citas: 12 [doi:10.1016/j.eimc.2013.06.002]

  • Serrano, D; Miralles, P; Balsalobre, P; Kwon, M; Rodriguez-Macias, G; Gayoso, J; Anguita, J; Buno, I; Berenguer, J; Diez-Martin, JL.

    Graft-Versus-Tumor Effect After Allogeneic Stem Cell Transplantation in HIV-Positive Patients With High-Risk Hematologic Malignancies

    AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013; 29(10): 1340-1345 Nº de citas: 10 [doi:10.1089/aid.2013.0001]

  • Guzman-Fulgencio, M; Berenguer, J; Micheloud, D; Fernandez-Rodriguez, A; Garcia-Alvarez, M; Jimenez-Sousa, MA; Bellon, JM; Campos, Y; Cosin, J; Aldamiz-Echevarria, T; Catalan, P; Lopez, JC; Resino, S.

    European mitochondrial haplogroups are associated with CD4+T cell recovery in HIV-infected patients on combination antiretroviral therapy

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013; 68(10): 2349-2357 Nº de citas: 17 [doi:10.1093/jac/dkt206]

  • Hernando, V; Alejos, B; Monge, S; Berenguer, J; Anta, L; Vinuesa, D; Palacios, R; Muga, R; Moreno, S; Jarrin, I.

    All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010

    BMC INFECTIOUS DISEASES. 2013; 13: Nº de citas: 18 [doi:10.1186/1471-2334-13-382]

  • Ribera, E; Larrousse, M; Curran, A; Negredo, E; Clotet, B; Estrada, V; Sanz, J; Berenguer, J; Rubio, R; Pulido, F; Ferrer, P; Alvarez, ML; Arterburn, S; Martinez, E.

    Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study

    HIV MEDICINE. 2013; 14(6): 327-336 Nº de citas: 11 [doi:10.1111/hiv.12011]

  • Demelo-Rodríguez P; González-Munera A; Tejerina F; Bernaldo De Quirós JC.

    Síndrome de Fitz-Hugh-Curtis en fase subaguda/crónica.

    Revista clínica espanõla. 2013; 213(5): [doi:10.1016/j.rce.2013.01.004]

  • Berenguer, J; Alvarez-Pellicer, J; Carrero, A; Von Wichmann, MA; Lopez-Aldeguer, J; Mallolas, J; Galindo, MJ; Van den Eynde, E; Tellez, MJ; Quereda, C; Tural, C; Sanz, J; Barros, C; Santos, I; Pulido, F; Guardiola, JM; Ortega, E; Rubio, R; Jusdado, JJ; Montes, ML; Gaspar, G; Barquilla, E; Bellon, JM; Gonzalez-Garcia, J.

    Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus

    JOURNAL OF HEPATOLOGY. 2013; 58(6): 1104-1112 Nº de citas: 23 [doi:10.1016/j.jhep.2013.01.042]

  • Pedrol, E; de Quiros, JCLB; Ruiz, S; Hevia, H; Ledesma, F.

    Reasons for the introduction of darunavir in the antirretroviral treatment in HIV-infected patients

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2013; 26(2): 103-107

  • Guzman-Fulgencio, M; Berenguer, J; Rallon, N; Fernandez-Rodriguez, A; Miralles, P; Soriano, V; Jimenez-Sousa, MA; Cosin, J; Medrano, J; Garcia-Alvarez, M; Lopez, JC; Benito, JM; Resino, S.

    HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

    AIDS. 2013; 27(8): 1231-1238 Nº de citas: 18 [doi:10.1097/QAD.0b013e32835f5b9c]

  • Jimenez-Sousa, MA; Berenguer, J; Rallon, N; Guzman-Fulgencio, M; Lopez, JC; Soriano, V; Fernandez-Rodriguez, A; Cosin, J; Restrepo, C; Garcia-Alvarez, M; Miralles, P; Benito, JM; Resino, S.

    IL28RA polymorphism is associated with early hepatitis C virus (HCV) treatment failure in human immunodeficiency virus-/HCV-coinfected patients

    JOURNAL OF VIRAL HEPATITIS. 2013; 20(5): 358-366 Nº de citas: 16 [doi:10.1111/jvh.12041]